{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "0904-3854",
      "generic_name": "CARBAMAZEPINE",
      "labeler_name": "Major Pharmaceuticals",
      "brand_name": "CARBAMAZEPINE",
      "active_ingredients": [
        {
          "name": "CARBAMAZEPINE",
          "strength": "100 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "0904-3854-61",
          "description": "100 BLISTER PACK in 1 CARTON (0904-3854-61)  / 1 TABLET, CHEWABLE in 1 BLISTER PACK",
          "marketing_start_date": "20100322",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {},
      "marketing_category": "ANDA",
      "dosage_form": "TABLET, CHEWABLE",
      "spl_id": "8c5d19ef-ad54-44a0-afdf-632120c5446c",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20100322",
      "product_id": "0904-3854_8c5d19ef-ad54-44a0-afdf-632120c5446c",
      "application_number": "ANDA075712",
      "brand_name_base": "CARBAMAZEPINE",
      "pharm_class": [
        "Cytochrome P450 1A2 Inducers [MoA]",
        "Cytochrome P450 2B6 Inducers [MoA]",
        "Cytochrome P450 2C19 Inducers [MoA]",
        "Cytochrome P450 2C9 Inducers [MoA]",
        "Cytochrome P450 3A4 Inducers [MoA]",
        "Decreased Central Nervous System Disorganized Electrical Activity [PE]",
        "Mood Stabilizer [EPC]"
      ]
    }
  ]
}